Five sites across India are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology Secretary Renu Swarup said on Monday. The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to...